Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
24
CLDI Quote, Financials, Valuation and Earnings
Last price:
$1.36
Seasonality move
:
-32.48%
Day range:
$1.28 - $1.38
52-week range:
$1.10 - $19.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.41x
Volume:
69.8K
Avg. volume:
136.8K
1-year change:
-92.18%
Market cap:
$9.7M
Revenue:
--
EPS (TTM):
-$6.74
Earnings Data
Next earnings date for CLDI
--
Most recent earnings per share
-$2.21
Missed by $2.21
(Nov 12/2025)
Consensus Estimate
--
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CLDI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2025 | Q3 | -- | -- | -$2.21 | -- | -- |
| 08/08/2025 | Q2 | -- | -- | -$1.99 | -$1.32 | -$0.67 |
| 05/14/2025 | Q1 | -- | -- | -$0.18 | -$1.80 | $1.62 |
| 03/31/2025 | Q4 | -- | -- | -$2.37 | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$0.06 | -- | -- |
| 08/13/2024 | Q2 | -- | -- | -$1.40 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$2.03 | -$32.40 | $30.37 |
| 03/15/2024 | Q4 | -- | -- | -$2.32 | -$24.00 | $21.68 |
| 11/14/2023 | Q3 | -- | -- | -$1.41 | -$20.40 | $18.99 |
| 06/30/2023 | Q2 | -- | -- | -$170.86 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$89.59 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$108.43 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$75.02 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | $1.45 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | $0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $1.49 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.29 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.00 | -- | -- |
Calidi Biotherapeutics, Inc. Earnings Questions
-
How Much did Calidi Biotherapeutics, Inc. Generate in Revenue Last Quarter?
Calidi Biotherapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Calidi Biotherapeutics, Inc. Beat Earnings Last Quarter?
Calidi Biotherapeutics, Inc. announced earnings per share of -$2.21 which represents a miss of analyst forecast a -- per share.
-
Is Calidi Biotherapeutics, Inc. Profitable?
Calidi Biotherapeutics, Inc. reported -$427K that represents -$0.09 per share over the last quarter.
-
What is the Analyst Consensus for Calidi Biotherapeutics, Inc. EPS Next Year?
Calidi Biotherapeutics, Inc.'s earnings are forecast to decrease from -$35.70 per share to -$0.45 per share next year representing a decrease of -84.87%.
-
When is Calidi Biotherapeutics, Inc.'s Earnings Date?
Currently, Calidi Biotherapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 22, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
